Our study found that the INR was increased in the over-whelming majority (91%) of patients following concomitant use of warfarin and short-term oral corticosteroids. Since most target INR ranges used ...
Abelacimab is a dual-acting, once-monthly, fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) - ...
In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...
The ISMP guidelines are not designed to be adopted unchanged by hospitals to represent the hospital's medication administration policies. Instead, the ISMP believes that each hospital (through an ...
In the first randomized trial of stroke prevention after ischemic stroke in patients who have both nonvalvular atrial fibrillation (AF, Afib) and atherosclerosis, adding an antiplatelet to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback